polymorphisms and adult glioma in a large, hospital-based case-control study, using unconditional logistic Accepted 15 November 2010 regression. DQB1*06 (OR = 1.67, 95% CI = 1.17-2.39) and DRB1*13 (OR = 1.69, 95% CI = 1.08-2.64) alleles were associated with an increased risk of glioma, while the DQB1*05 allele showed an inverse association Keywords:
Introduction
Glioma is the most aggressive and common form of brain cancer, accounting for about 80% of primary malignant brain tumors (Central Brain Tumor Registry of the United States, 2010). The survival rate for glioma patients is characteristically poor, with less than 25% of individuals surviving past five years (Barnholtz-Sloan et al., 2007) . Outcomes are much worse for patients with the most common form of glioma, glioblastoma multiforme (GBM), with a five-year survival rate of less than 5% (Barnholtz-Sloan et al., 2007) . While the etiology of glioma is not well elucidated, increasing evidence has pointed to the role of immunological and genetic factors in the development and progression of these tumors ([Rajaraman et al., 2009] , [Scheurer et al., 2008] , [Brenner et al., 2007] and [Wrensch et al., 2006] ). Specifically, epidemiologic evidence has suggested a consistent inverse relationship between glioma and a prior history of allergy and, to a lesser extent, autoimmune disease ([Wiemels et al., 2008] , [Brenner et al., 2002] , [Schoemaker et al., 2006] , [Wigertz et al., 2007] and [Il'yasova et al., 2009] ). The observed relationship between glioma and immune-related disorders has been further supported by the observation that genetic polymorphisms in cytokine genes have been associated with both glioma susceptibility and survival ([Scheurer et al., 2008] , [Brenner et al., 2007] and [Schwartzbaum et al., 2005] ). Interestingly, specific polymorphisms associated with an increased risk of asthma were previously shown to be associated with a decreased risk of glioblastoma [Schwartzbaum et al., 2005] .
It is well established that polymorphisms in human leukocyte antigen (HLA) genes, responsible for antigen presentation and initiation of immune response, are related to risk of autoimmune diseases and allergic conditions, including celiac disease (Karell et al., 2003) , type I diabetes ([Gorodezky et al., 2006] and [Erlich et al., 2008] ), rheumatoid arthritis ([Tuokko et al., 2001] and [Seidl et al., 2001] ), as well as risk of asthma (Juhn et al., 2007) and other atopic conditions ([Schubert et al., 2004] and [Sénéchal et al., 1999] ). In addition to the associations with autoimmune diseases and allergies, polymorphisms in HLA genes have been found to be associated with susceptibility to several cancers, including ovarian (Kubler et al., 2006) , breast (Chaudhuri et al., 2000) , and cervical cancer ([Castro et al., 2009] and [Hildesheim et al., 1998 ]), and malignant melanoma (Bateman et al., 1998) .
With regard to glioma, evidence has been limited and inconsistent, with only a few small studies that have examined polymorphisms in HLA genes as a potential susceptibility factor ([Guerini et al., 2006] , Journal of Neuroimmunology 233 (2011) 185-191 
